Introduction: Haematological malignancies like other cancers are on the rise. With the improved understanding of the biology of cancers, various biological molecules (biologics and biosimilars) are being discovered and used as supportive and/or specific treatment options. These novel treatments have revolutionized the care of cancer patients and significantly improved survival.
View Article and Find Full Text PDFBackground: The prevalence of gastroesophageal reflux disease (GERD) in Africa is not known but is believed to be increasing because of demographic and epidemiologic transition. The main objectives of this study were to determine the prevalence and risk factors of GERD, and its degree of overlap with dyspepsia and irritable bowel syndrome (IBS) in Nigeria, a typical African population.
Methods: This was an observational, cross-sectional and descriptive study of adult Nigerians.